Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/29/2009 | US20090269751 Dot1 histone methyltransferases as a target for identifying therapeutic agents for leukemia |
10/29/2009 | US20090269740 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells |
10/29/2009 | US20090269739 Kit for detection of telomerase reverse transcriptase nucleic acids |
10/29/2009 | US20090269619 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
10/29/2009 | US20090269475 Soybean Cultivar 7240440 |
10/29/2009 | US20090269474 Soybean Cultivar S070155 |
10/29/2009 | US20090269473 Soybean Cultivar 72143110 |
10/29/2009 | US20090269472 Soybean Cultivar 76171112 |
10/29/2009 | US20090269471 Soybean Cultivar S070154 |
10/29/2009 | US20090269470 Soybean Cultivar 7401262 |
10/29/2009 | US20090269469 Soybean Cultivar S070153 |
10/29/2009 | US20090269468 Soybean Cultivar 7907301 |
10/29/2009 | US20090269467 high yielding soybean cultivars that are agronomically sound; transgenic soybeans with disease resistance, insect resistance and other agronomic traits |
10/29/2009 | US20090269466 Soybean Cultivar 26650228 |
10/29/2009 | US20090269465 Soybean Cultivar 27063030 |
10/29/2009 | US20090269464 Soybean Cultivar S070156 |
10/29/2009 | US20090269463 Soybean Cultivar 7034069 |
10/29/2009 | US20090269462 Soybean Cultivar 7803418 |
10/29/2009 | US20090269461 Soybean Cultivar 7733084 |
10/29/2009 | US20090269460 Soybean Cultivar 7904162 |
10/29/2009 | US20090269437 Glycerol channel gene and use thereof |
10/29/2009 | US20090269371 Process for the production of monoclonal antibodies |
10/29/2009 | US20090269368 Pseudomonas exotoxin a-like chimeric immunogens |
10/29/2009 | US20090269366 T cell epitope peptides of 6b11 ovarian cancer anti-idiotypic antibody |
10/29/2009 | US20090269365 Immunogenic vaccinia peptides and methods of using same |
10/29/2009 | US20090269361 Constructs for delivery of therapeutic agents to neuronal cells |
10/29/2009 | US20090269358 Proteins with Improved Solubility and Methods for Producing and Using Same |
10/29/2009 | US20090269356 Complement Binding Aptamers and Anti-C5 Agents Useful in the Treatment of Ocular Disorders |
10/29/2009 | US20090269355 Catalytic antibodies and a method of producing same |
10/29/2009 | US20090269349 Antigenic polypeptides |
10/29/2009 | US20090269348 Pancreatic Cancer Genes |
10/29/2009 | US20090269347 Pancreatic Cancer Genes |
10/29/2009 | US20090269342 Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto |
10/29/2009 | US20090269338 Humanized anti-factor d antibodies and uses thereof |
10/29/2009 | US20090269333 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
10/29/2009 | US20090269331 Caspase-8 and inflammation, infection and wound healing |
10/29/2009 | US20090269327 isolated from Coprinus clastophyllus; for treating celiac disease caused by proline abundant gluten |
10/29/2009 | US20090269326 nucleic acid molecule which codes for 6-O-sulfatase or N-sulfamidase; degrading monosaccharides or polysaccharides with the molecules; degrading glycosaminoglycan |
10/29/2009 | US20090269320 Variants of pigment epithelium derived factor and uses thereof |
10/29/2009 | US20090269306 N-terminal modified interferon-alpha |
10/29/2009 | US20090269285 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
10/29/2009 | US20090266760 Functional nucleic acids for biological sequestration |
10/29/2009 | DE102008020258A1 Stabile Lysepuffermixtur zur Extraktion von Nukleinsäuren Lysepuffermixtur stable for extracting nucleic acids |
10/29/2009 | DE10154290B4 Verfahren zum Nachweis Parodontitis und Karies assoziierter Bakterien A method for detecting periodontal disease and caries-associated bacteria |
10/29/2009 | CA2722589A1 Improved tlr3 agonist compositions |
10/29/2009 | CA2722440A1 Isoprene synthase variants for improved microbial production of isoprene |
10/29/2009 | CA2722329A1 Artificial protein scaffolds |
10/29/2009 | CA2722316A1 Gene expression profiling based identification of genomic signature of high-risk multiple myeloma and uses thereof |
10/29/2009 | CA2722278A1 Systems, methods and compositions for optical stimulation of target cells |
10/29/2009 | CA2722276A1 Recombinant cells and methods for hydroxylating fatty acids |
10/29/2009 | CA2722275A1 Polypeptides and methods for producing triacylglycerols comprising modified fatty acids |
10/29/2009 | CA2722238A1 Liver-specific nucleic acid regulatory elements and methods and use thereof |
10/29/2009 | CA2722189A1 Methods and materials for processing a feedstock |
10/29/2009 | CA2722145A1 Rehydratable thiolated polysaccharide particles and sponge |
10/29/2009 | CA2722043A1 Nucleic acid comprising chimeric gene derived from hepatitis c virus |
10/29/2009 | CA2721933A1 Improved strains of zymomonas mobilis for fermentation of biomass |
10/29/2009 | CA2721879A1 Plant seed oil |
10/29/2009 | CA2721870A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
10/29/2009 | CA2721833A1 Prion epitopes and methods of use thereof |
10/29/2009 | CA2721807A1 Transformation and engineered trait modification in miscanthus species |
10/29/2009 | CA2721719A1 Use of disk surface for electroporation of adherent cells |
10/29/2009 | CA2721716A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
10/29/2009 | CA2721582A1 Recombinant deamidated gliadin antigen |
10/29/2009 | CA2721372A1 Plant viral expression vectors and use of same for generating genotypic variations in plant genomes |
10/29/2009 | CA2720903A1 Linear donor constructs for targeted integration |
10/29/2009 | CA2719267A1 Abi1/hssh3bp1 conditional knockout mouse |
10/29/2009 | CA2718335A1 Drought tolerant plants and related constructs and methods involving genes encoding protein tyrosine phosphatases |
10/29/2009 | CA2713165A1 Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof |
10/29/2009 | CA2664405A1 Methods of altering plant phenotypes by suppressing function of cil1 protein or homolog thereof |
10/28/2009 | EP2112234A2 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy |
10/28/2009 | EP2112233A1 Pyrophosphorolysis activated polymerization (PAP): application to allele-specific amplification and nucleic acid sequence determination |
10/28/2009 | EP2112231A2 MarA family helix-turn-helix domains and methods of use |
10/28/2009 | EP2112225A1 Recombinant pox virus for immunization against tumor-associated antigens |
10/28/2009 | EP2112224A2 Development of novel germplasm using segregates from transgenic crosses |
10/28/2009 | EP2112223A2 DOF (DNA binding with one finger) sequences and method of use |
10/28/2009 | EP2112222A1 Gene encoding guanine nucleotide exchange factor and gene product thereof |
10/28/2009 | EP2112221A1 Hybrid H1 Promoter for shRNA Expression |
10/28/2009 | EP2112220A2 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
10/28/2009 | EP2112166A2 Human monoclonal antibodies to CTLA-4 |
10/28/2009 | EP2112165A2 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
10/28/2009 | EP2112159A2 Immuno-interactive fragments of the alpha C subunit of inhibin |
10/28/2009 | EP2111748A1 Cytoplasmic male sterile rucola |
10/28/2009 | EP2111458A1 Method and apparatus for sustaining viability of biological cells on a substrate |
10/28/2009 | EP2111457A2 Methods and compositions for modulating the mirna pathway |
10/28/2009 | EP2111456A1 Use of trehalase genes to confer nematode resistance to plants |
10/28/2009 | EP2111455A1 Polynucleotides encoding truncated sucrose isomerase polypeptides for control of parasitic nematodes |
10/28/2009 | EP2111454A1 Genetically modified yeasts for the production of homogeneous glycoproteins |
10/28/2009 | EP2111453A1 Mutations in lama2 gene of zebrafish |
10/28/2009 | EP2111452A1 Compositions and methods using rna interference of opr3-like gene for control of nematodes |
10/28/2009 | EP2111451A1 Compositions and methods using rna interference for control of nematodes |
10/28/2009 | EP2111450A2 Nucleic acid constructs and methods for specific silencing of h19 |
10/28/2009 | EP2111449A2 H19 silencing nucleic acid agents for treating rheumatoid arthritis |
10/28/2009 | EP2111448A1 Inhibition of gene expression |
10/28/2009 | EP2111411A1 A functional r-gene from solanum bulbocastanum |
10/28/2009 | EP2111218A1 Dna controlled assembly of lipid membranes |
10/28/2009 | EP1899378B1 Il-1 beta binding antibodies and fragments thereof |
10/28/2009 | EP1891215B1 Highly safe intranasally administrable gene vaccines for treating alzheimer's disease |
10/28/2009 | EP1888625B1 Malaria vaccines |
10/28/2009 | EP1877551B1 Polypeptides having endoglucanase activity and polynucleotides encoding same |
10/28/2009 | EP1869179B1 Method for treating a sample that contains biomolecules |